NewsIn memory
Jacqueline Kennedy Onassis: Understanding Lymphoma
Flu-like symptoms led to a non-Hodgkin lymphoma diagnosis in January 1994. She died four months later. What the public record says about her illness.
Original commentary from the Cancer Explained editorial team.
Historical context: this page explains an event dated 1994. It was published as an explainer on July 12, 2026 and is not breaking news.
Please note: this page is educational only — it is not medical advice, and it does not speculate about anyone’s health beyond reliable public reporting. For questions about your own health, talk with your healthcare team.
It started as flu-like symptoms
In February 1994, Jacqueline Kennedy Onassis' spokeswoman, Nancy Tuckerman, told reporters what had happened the month before.
Flu-like symptoms had sent her to a doctor in early January. She was diagnosed with non-Hodgkin's lymphoma, a cancer of the lymphatic system. She was 64, worked as a senior editor at Doubleday, and was known for good health and early morning runs around the Central Park reservoir.
Tuckerman said the illness was disclosed only to answer rumors, that Onassis was responding well to treatment, and that doctors believed the cancer had been caught early. Onassis kept working.
UPI reported in April that she was hospitalized for a bleeding ulcer, which was believed to be linked to her chemotherapy.
She was admitted again in May with what was described as serious complications, then discharged at her own request. She died at her New York apartment on the evening of May 19, 1994. Her daughter, her son and her longtime companion were with her.
That is the public record. We add nothing to it.
Why the beginning is the part worth studying
The first line of her story is the most useful one, and it is easy to skim past.
Flu-like symptoms. Not a lump anyone could see. Not pain.
Non-Hodgkin lymphoma often announces itself that way. NCI's symptom list is a set of things that all have ordinary explanations most of the time.
- Swelling of lymph nodes in the neck, underarm, groin or stomach.
- Fever for no known reason.
- Drenching night sweats.
- Feeling very tired.
- Weight loss for no known reason.
- A skin rash, or itchy skin.
- Pain in the chest, abdomen or bones for no known reason.
When to get checked
Most swollen nodes are the immune system doing its job during an infection, and they settle in a few weeks.
What changes the picture is time and company. A node that has not gone down after several weeks, with no infection to explain it, is worth showing a doctor. So is any of that list appearing alongside fever, drenching night sweats or weight loss you did not intend.
NCI groups fever, drenching night sweats and unexplained weight loss under one name: B symptoms. When they occur together, they get recorded as part of the stage, because they carry information about the disease. Our page on lymphoma symptoms goes through each one.
There is no screening test for lymphoma in the general population. Noticing is the only early step there is.
What the disease actually is
Non-Hodgkin lymphoma is not one cancer. It is a large family of cancers of the lymph system, which is part of the immune system.
Lymph is a colorless fluid that travels through vessels and nodes carrying lymphocytes, a type of white blood cell. There are three kinds: B cells, which make antibodies, T cells, which help them, and natural killer cells. NCI says most non-Hodgkin lymphomas begin in B cells.
The first split NCI makes is by speed rather than by stage. Some are indolent, meaning slow-growing. Some are aggressive. The two are handled very differently, and an indolent lymphoma is sometimes watched rather than treated straight away.
Diagnosis needs tissue from a lymph node, read by a pathologist, plus blood tests and imaging to see how far it has spread. Treatment may use chemotherapy, antibodies aimed at markers on B cells, radiation, or a stem cell transplant. Our page on lymphoma covers how the subtypes differ.
The chemotherapy detail
The April hospital stay is worth a paragraph of its own, because it describes something that has not gone away.
A bleeding ulcer linked to chemotherapy is not a rare kind of bad luck. Chemotherapy affects fast-dividing cells, and the lining of the stomach and gut is full of them. Complications from treatment are part of treatment, not a separate story from it.
That is why care teams ask about black or tarry stools, vomiting that looks like coffee grounds, sudden abdominal pain, or new dizziness during chemotherapy. Those are same-day calls.
What to keep in perspective
The numbers of 1994 were not the numbers of today. UPI's report at the time cited a five-year survival figure of about 52 percent for non-Hodgkin lymphoma.
Current SEER data puts five-year relative survival at 74.3 percent for cases diagnosed from 2016 to 2022. By stage it runs 87.6 percent at stage I, 79.7 percent at stage II, 74.0 percent at stage III, and 63.6 percent at stage IV. For 2026 the American Cancer Society estimates 79,320 new cases and 19,970 deaths, a forecast SEER hosts.
Two cautions belong with those figures. They describe a large group across the whole country, not any individual. And they cover dozens of different diseases averaged together, so the number for one subtype may sit well above or below the headline. Our page on cancer survival statistics explains what a relative survival figure is measuring.
One more thing this story cannot tell you. Being told a cancer was caught early is a statement about what was visible at that moment, not a guarantee about what follows. Her own course made that plain within four months.
Sources
- UPI Archives, Feb. 11, 1994, Jackie Onassis undergoes cancer treatment — https://www.upi.com/Archives/1994/02/11/Jackie-Onassis-undergoes-cancer-treatment/5778760942800/
- UPI Archives, May 20, 1994, Jacqueline Kennedy Onassis dead at 64 — https://www.upi.com/Archives/1994/05/20/Jacqueline-Kennedy-Onassis-dead-at-64/7269769406400/
- NCI PDQ, Adult Non-Hodgkin Lymphoma Treatment (Patient Version) — https://www.cancer.gov/types/lymphoma/patient/adult-nhl-treatment-pdq
- SEER Cancer Stat Facts, Non-Hodgkin Lymphoma — https://seer.cancer.gov/statfacts/html/nhl.html
How this article was prepared
An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.
The National Cancer Information Foundation publishes Cancer Explained. This page is for learning. It is not medical advice and does not suggest a test or treatment.
See an error, old source, or unclear wording? Tell us.
Know someone who needs this?
Plenty of people are looking for something like this and do not know where to start. If this would help a friend or someone you love, send it on — we have written an opening line so you do not have to stare at an empty message. You can change every word of it.
Your message is written and sent in your own email or messaging app — we never see who you send it to, and nothing is added to any list.
Put the story in context
Prevention, possible warning signs, screening, and diagnosis
This story relates to Lymphoma. The information below is general: it does not reveal anything else about a public person’s health, and not every point applies to every cancer. Personal advice depends on age, symptoms, family history, exposures, and medical history.
Prevention and risk reduction
Not every cancer can be prevented. Avoiding tobacco, protecting skin from ultraviolet radiation, limiting alcohol, staying active, and receiving recommended HPV or hepatitis B vaccination can lower the risk of certain cancers. A risk factor is not a prediction or a cause in one individual.
Symptoms and possible early signs
Possible signs vary and are often caused by conditions other than cancer. Changes worth discussing include a new lump, unexplained bleeding or weight loss, a persistent cough, lasting bowel or bladder changes, a changing skin spot, or symptoms that persist or worsen. Some early cancers cause no symptoms.
Screening and early detection
Screening looks for certain cancers before symptoms begin. Recommended tests exist only for some cancers and depend on age and risk. Screening can have benefits and harms; it is not the same as evaluating a new symptom, and there is no single routine scan or blood test that reliably screens for every cancer.
How cancer is diagnosed
Diagnosis may involve a history and exam, imaging, laboratory tests, and often a biopsy. Pathology can identify the cancer type and may test biomarkers that guide treatment. Symptoms, screening results, tumor markers, or online stories alone cannot confirm cancer.
Learn about this story’s cancer topic
A public story may encourage questions, but it should not be used to estimate your risk or choose testing. Contact a healthcare professional about a persistent or concerning change. Seek urgent care for severe or rapidly worsening symptoms.